Foster Group, Inc. Amgen Inc Transaction History

Foster Group, Inc.

$2.57 Billion
Q3 2024

A detailed history of Foster Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Foster Group, Inc. holds 1,490 shares of AMGN stock, worth $417,304. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,490

Previous 1,444 3.19%

Holding current value

$417,304

Previous $451,000 6.43%

% of portfolio

0.02%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$309.38 - $337.38 $14,231 - $15,519	46 Added 3.19%	1,490 $480,000
Q2 2024 Jul 30, 2024	BUY	$262.75 - $319.31 $2,890 - $3,512	11 Added 0.77%	1,444 $451,000
Q1 2024 Apr 09, 2024	BUY	$268.87 - $324.56 $9,141 - $11,035	34 Added 2.43%	1,433 $407,000
Q3 2023 Oct 27, 2023	BUY	$218.65 - $271.46 $51,601 - $64,064	236 Added 20.29%	1,399 $375,000
Q2 2023 Jul 10, 2023	SELL	$214.27 - $253.37 $29,140 - $34,458	-136 Reduced 10.47%	1,163 $258,000
Q1 2023 Apr 06, 2023	BUY	$225.79 - $275.2 $15,579 - $18,988	69 Added 5.61%	1,299 $314,000
Q4 2022 Jan 23, 2023	SELL	$229.03 - $291.01 $24,735 - $31,429	-108 Reduced 8.07%	1,230 $0
Q3 2022 Oct 13, 2022	BUY	$224.46 - $253.15 $13,243 - $14,935	59 Added 4.61%	1,338 $302,000
Q2 2022 Jul 25, 2022	BUY	$230.71 - $256.74 $33,452 - $37,227	145 Added 12.79%	1,279 $311,000
Q1 2022 Apr 22, 2022	BUY	$219.27 - $242.57 $657 - $727	3 Added 0.27%	1,134 $274,000
Q4 2021 Feb 02, 2022	SELL	$198.88 - $227.6 $4,972 - $5,690	-25 Reduced 2.16%	1,131 $254,000
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $6,368 - $7,461	-30 Reduced 2.53%	1,156 $246,000
Q2 2021 Aug 09, 2021	BUY	$233.58 - $259.14 $6,773 - $7,515	29 Added 2.51%	1,186 $289,000
Q4 2020 Jan 21, 2021	BUY	$216.38 - $257.67 $250,351 - $298,124	1,157 New	1,157 $259,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Foster Group, Inc. with notifications on news.

Account